Drug Testing Locations - Pimaco Two, AZ

Drug Testing in Pimaco Two, AZ

Pimaco Two, Arizona Statistics

In Pimaco Two, AZ, Pima County, the opioid overdose rate has increased by 25% from 2021 to 2022.

In 2022, there were over 150 drug-related arrests reported in Pimaco Two, Pima County.

Pima County reported a 15% rise in juvenile drug abuse cases in Pimaco Two during 2022.

The Methamphetamine use in Pimaco Two, Pima County, has seen a 10% increase over the past year.

In Pimaco Two, nearly 5% of adults have reported illicit drug use in the past month as of 2022.

How does the body eliminate Drugs

Drug elimination is the sum of the processes of removing an administered drug from the body. In the pharmacokinetic ADME scheme (absorption, distribution, metabolism, and excretion), it is frequently considered to encompass both metabolism and excretion. Hydrophobic drugs, to be excreted, must undergo metabolic modification making them more polar. Hydrophilic drugs, on the other hand, can undergo excretion directly, without the need for metabolic changes to their molecular structures.

Although many sites of metabolism and excretion exist, the chief organ of metabolism is the liver, while the organ primarily tasked with excretion is the kidney. Any significant dysfunction in either organ can result in the accumulation of the drug or its metabolites in toxic concentrations.

A variety of other factors impact elimination — intrinsic drug properties, such as polarity, size, or pKa. Also other factors include genetic variation among individuals, disease states affecting other organs, and pathways involved in the way the drug distributes through the body, such as first-pass metabolism.

Issues of Concern

Drug elimination is the removal of an administered drug from the body. It is accomplished in two ways, either by excretion of an unmetabolized drug in its intact form or by metabolic biotransformation followed by excretion. While excretion is primarily carried out by the kidneys, other organ systems are involved as well. Similarly, the liver is the primary site of biotransformation, yet extrahepatic metabolism takes place in a variety of organ systems affecting multiple drugs.

Given the multiple organ systems and the variety of metabolic transformations present, drug elimination can entail a significant degree of complexity. Hydrophilic drugs are typically directly excreted by the kidneys, while hydrophobic drugs undergo biotransformation before excretion. The purpose here is twofold – biotransformation serves both detoxify the exogenous substances as well as to increase their hydrophilicity, ensuring their elimination via the kidneys.

Two broad metabolic pathways of hepatic drug transformation exist. Phase I is the direct modification of the target molecule, whereas phase II entails conjugation of the target to a polar molecule of low molecular weight. Phase I prepare the drug to enter phase II, but single-phase metabolism also exists.

Phase I involves oxidation, reduction, and hydrolysis of the exogenous molecule. These reactions are accomplished by hepatic microsomal enzymes, which reside in the smooth endoplasmic reticulum of the hepatocytes. Best known among them is the cytochrome P450 system, whose enzymes are predominantly involved in oxidative metabolism. Within the cytochrome P450 family (CYP), the enzyme responsible for the metabolism of more than 50% of existing drugs is the CYP3A4. Its activity encompasses various classes of medications, including opioids, immunosuppressants, antihistamines, and benzodiazepines. The enzymes can also be induced or inhibited by a variety of substances they interact with, including pharmaceuticals. The increase in metabolic activity with CYP induction results in a diminished activity of drugs targeted by that particular isoform. Conversely, CYP inhibition will result in increased drug plasma concentration, potentially leading toxicity. The CYP3A4 is induced by phenytoin, phenobarbital, and St. John's wort, while diltiazem, erythromycin, and grapefruit inhibit it. Caution is, therefore, necessary when administering CYP3A4-metabolized drugs in the presence of any of the inhibitors or inducers.

Phase II consists of covalent bonding of polar groups to nonpolar molecules to render them water-soluble and allow renal or biliary excretion. Target molecules enter phase II directly or via initial processing through phase I. A variety of polar adjuncts is transferred, including amino acids, glucuronic acid, glutathione, acetate, and sulfate. Glucuronidation is one of the major pathways of phase II biotransformation. The UDP-glucuronosyltransferase (UGT) enzyme family performs this activity. Typically, glucuronide derivatives possess less or no activity of the original drug, but in some cases, pharmacologically active compounds result. Morphine-6-glucuronide is a phase II metabolite of morphine with significant analgesic activity. As with the CYP enzymes, inducers, and inhibitors of phase II, enzymes exist and may influence the efficacy of drugs that rely on conjugation before excretion.

The first-pass effect is a feature of hepatic metabolism that also plays a role in the elimination of multiple drugs. Here, the enteric consumed drugs are exposed directly to the liver via the portal vein, where they undergo biotransformation before entering the systemic circulation. This activity reduces the bioavailability and needs to be factored into the dose administered to the patient. Intravenously administered drugs are not subject to the first-pass effect.

Extrahepatic drug metabolism takes place in the GI tract, kidneys, lungs, plasma, and skin.

Renal excretion completes the process of elimination that begins in the liver. Polar drugs or their metabolites get filtered in the kidneys and typically do not undergo reabsorption. They subsequently get excreted in the urine. Urinary pH has a significant impact on excretion, as drug ionization changes depending on the alkaline or acidic environment. Increased excretion occurs with weakly acidic drugs in basic urine and weakly basic drugs in acidic urine.

Excretion in the bile is another significant form of drug elimination. The liver can actively secrete ionized drugs with a molecular weight greater than 300 g/mol into bile, from where they reach the digestive tract and are either eliminated in feces or reabsorbed as part of the enterohepatic cycle.

Other pathways of excretion include the lungs, breast milk, sweat, saliva, and tears

Employers in Pimaco Two, AZ & Drug Testing Policies

Employers in Pimaco Two, AZ, are proactive in enforcing strict drug testing policies to maintain a safe and productive work environment. Many local businesses align with federal guidelines as outlined by SAMHSA to conduct pre-employment drug testing.

Periodic and random drug tests are increasingly common in Pimaco Two, especially within industries involving heavy machinery and public safety. These tests aim to minimize the risk of accidents and ensure employee well-being. Legislative support from the Arizona Commerce Authority aids companies by providing resources for workforce management and drug-free workplace policies.

Government Efforts with Drug Problems in Pimaco Two, AZ

The government of Pimaco Two, AZ, alongside Pima County authorities, has intensified efforts to combat drug problems through increased funding for local rehabilitation centers. Collaborative efforts with state and federal agencies such as Arizona Department of Health Services aim to provide more community support and outreach initiatives.

Pimaco Two authorities have also implemented the Pima County's Criminal Justice Reform Unit's recommendations to reduce recidivism among drug offenders. More resources and programs are offered to educate and prevent drug use among residents, with great emphasis on youth programs. State-level collaboration with the Arizona High-Intensity Drug Trafficking Area also assists in tracking and reducing drug trafficking in Pimaco Two.

Local Drug Busts & News in Pimaco Two, AZ

Pimaco Two has witnessed several notable drug busts that highlight ongoing issues. In early 2023, a significant methamphetamine trafficking ring was dismantled by a joint task force involving local and federal authorities. This operation resulted in multiple arrests and significant drug seizures.

Additionally, Pimaco Two Police Department, in collaboration with Pima County Sheriff's Department, conducted a successful operation targeting opioid distributors in mid-2022, which led to a marked reduction in local circulation. Such operations are pivotal in the county's ongoing battle against drug-related activities in the region.

Occupational Health Services

Accredited Drug Testing offers fast, reliable employment screening services in Pimaco Two, AZ. Trusted by employers nationwide for accurate results and exceptional service.

Arizona DOT/Non DOT Physicals

Arizona Vision Tests

Arizona Audiograms

Arizona Respirator Fit Tests

Arizona Lift Tests

Arizona Background Checks

Clinical Testing Services

TB Testing in AZ

Diabetes Testing in AZ

Infectious Disease Testing in AZ

Sickle Cell Anemia Testing in AZ

Women/Men's Health Testing in AZ

Resources & Citations

Arizona Department of Health Services - Behavioral Health

Governor's Office of Youth, Faith and Family Substance Abuse

Pima County Health Department

Community Bridges

Caron Treatment Centers Arizona

Sahuarita Community Resources

MHC Healthcare

Southwest Detox

La Frontera Arizona

Caron Treatment Centers Arizona

Drug Testing Near Pimaco Two, AZ

Elgin, AZ

Corona de Tucson, AZ

Whetstone, AZ

Rincon Valley, AZ

Vail, AZ

St. David, AZ

Saint David, AZ

Curtiss, AZ

Benson, AZ

Pantano, AZ

Mescal, AZ

Frequently Asked Questions

Customer Reviews